A plain-language guide to checking care
Regenerative providers.
Check the offer first.
Regenerative means regrowth or repair. If your search has led to peptide care, begin with the treatment’s exact name.
Protein building blocks linked in a small chain form a peptide. Then check the person, the product, and the full price.
Take the question sheetA clear answer is a fair ask.
Make the offer clear
What kind of product is it?
The word regenerative does not name the treatment being offered. Ask for its exact name, what it is meant to treat, and which type of product below it is.
FDA is short for Food and Drug Administration, the U.S. drug agency.
- FDA-approved medicine
Semaglutide is in two medicines: Ozempic, used for type 2 diabetes, and Wegovy, used for weight loss. These products have U.S. approval as of September 2026.
Approval is for a named product and a particular use, not for every treatment called a peptide.
Ask which product is being offered and what condition it is meant to treat.
Source B- Compounded medicine
With compounding, a licensed pharmacist or doctor prepares medicine for a patient rather than providing a ready-made drug.
As of September 2026, U.S. rules allow some medicines to be made this way without FDA approval.
This may help a patient who needs a medicine without a dye that causes an allergy, or a form they can swallow.
A ready-made medicine may also be unavailable.
U.S. rules also limit copying ready-made medicines. The question sheet explains that rule.
Read the rule about making copiesFDA does not review a compounded medicine’s safety, quality, or ability to work before sale.
FDA warns that poor compounding can leave germs in a drug or the wrong amount of the ingredient that does the work.
Source C- Research use only
FDA warns, as of September 2026, against weight-loss products marked for research but offered for people to use.
These products have unknown quality and may harm your health.
Pause when a treatment offer points you toward a research chemical.
Source D
Choose a route to care
In a room or over a screen
Compare a visit in person with a visit by phone or online.
With telehealth, you receive care by video, phone, or an online exchange instead of sharing a room with the person treating you.
Your location matters.
As of September 2026, a doctor giving telehealth care needs permission to practise in the state you are physically in during that visit.
Some states let a doctor licensed elsewhere sign up for permission to provide online care, a process called telehealth registration.
That permission usually does not allow an office or visits in person in that state.
Ask how the service checks that permission, including when you travel.
Source ETurn an offer into a conversation
What to bring to a visit
Your goal, in your own words
Write down what bothers you and what you hope to change. Bring the names of your current medicines and your main questions.
Space to discuss other options
Ask what else might explain the problem. Ask about other treatments, and what happens if you wait.
A plan for the next conversation
Before agreeing, ask who to reach after the visit, how the plan will be reviewed, and how to get your records.
Keep the questions together
Check the person. Name the medicine. Get the total.
Take the question sheet into your next conversation about care.
The page footnotes
Read what supports these checks
Peptides and drug rules
Approved semaglutide products
Research-labelled products
Permission to practise where you are
Assessment and follow-up